Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
7.43B | 8.16B | 7.95B | 6.89B | 5.99B | Gross Profit |
1.79B | 1.75B | 1.49B | 1.33B | 1.27B | EBIT |
883.00M | 957.00M | 762.00M | 709.00M | 582.00M | EBITDA |
1.18B | 1.17B | 978.00M | 543.00M | 801.00M | Net Income Common Stockholders |
647.00M | 643.00M | 492.00M | 117.00M | 348.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.01B | 409.00M | 239.00M | 332.00M | 665.00M | Total Assets |
7.44B | 7.64B | 7.56B | 7.00B | 6.86B | Total Debt |
1.83B | 2.40B | 2.48B | 2.05B | 2.32B | Net Debt |
834.00M | 2.00B | 2.25B | 1.72B | 1.66B | Total Liabilities |
3.55B | 4.05B | 4.30B | 3.77B | 3.79B | Stockholders Equity |
3.80B | 3.54B | 3.19B | 3.14B | 2.98B |
Cash Flow | Free Cash Flow | |||
1.44B | 741.00M | -148.00M | 92.00M | 496.00M | Operating Cash Flow |
1.44B | 1.06B | 152.00M | 392.00M | 829.00M | Investing Cash Flow |
-47.00M | -329.00M | -320.00M | -335.00M | -571.00M | Financing Cash Flow |
-765.00M | -569.00M | 103.00M | -373.00M | 143.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $84.45B | 19.07 | 17.12% | 2.72% | 1.18% | -5.47% | |
73 Outperform | $28.43B | 21.22 | 35.58% | 2.74% | -16.16% | 41.01% | |
72 Outperform | $8.29B | 13.29 | 17.01% | 2.45% | -8.95% | 1.35% | |
66 Neutral | $12.16B | 24.89 | 5.60% | 5.37% | -2.00% | -50.02% | |
65 Neutral | $9.61B | 8.97 | 11.47% | 3.79% | -10.78% | -45.77% | |
63 Neutral | $20.85B | 13.27 | -10.88% | 7.48% | 1.13% | 11.50% | |
60 Neutral | $22.34B | 12.76 | 8.12% | 4.32% | -9.01% | -43.53% |
Ingredion Incorporated is set to showcase its upcoming 2024 Texture Innovation Day, where senior executives will present potential growth strategies. While these presentations may include forward-looking statements about future outcomes, they come with inherent risks and uncertainties. Investors should be aware that actual results could vary significantly from current expectations.